UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 403

Sortiert nach

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

PloS one, 2014-07, Vol.9 (7), p.e101510-e101510

2014

Volltextzugriff (PDF)

Clade-Specific Flucytosine Resistance Is Due to a Single Nucleotide Change in the FUR1 Gene of Candida albicans

Antimicrobial Agents and Chemotherapy, 2004-06, Vol.48 (6), p.2223-2227

2004

Volltextzugriff (PDF)

Correction: Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019)

Journal of antibiotics, 2022-02, Vol.75 (2), p.123-123

2022

Volltextzugriff (PDF)

Invasive Mycoses: Evolving Challenges and Opportunities in Antifungal Therapy (Multimedia Activity)

The American journal of medicine, 2011-10, Vol.124 (10), p.S2-S3

2011

Volltextzugriff (PDF)

Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012–2014

The Pediatric infectious disease journal, 2017-05, Vol.36 (5), p.486-491

2017

Volltextzugriff (PDF)

Manual of Clinical Microbiology

11th edition., 2015

Volltextzugriff (PDF)

Evaluation of the in vitro activity of daptomycin against 19 615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002–2005)

Diagnostic microbiology and infectious disease, 2007, Vol.57 (4), p.459-465

2007

Volltextzugriff (PDF)

Molecular Medical Microbiology, Three-Volume Set

1, 2001

Volltextzugriff (PDF)

Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy

Diagnostic microbiology and infectious disease, 2003-08, Vol.46 (4), p.253-257

2003

Volltextzugriff (PDF)

Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial

JAMA : the journal of the American Medical Association, 1991-05, Vol.265 (18), p.2364

1991

Volltextzugriff (PDF)

Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program

The Brazilian journal of infectious diseases, 2001-08, Vol.5 (4), p.200-214

2001

Volltextzugriff (PDF)

1292. Activity of Omadacycline and Comparators Against 876 Bacterial Clinical Isolates from Patients with Bone and Joint Infections in the United States and Europe (2015–2022)

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

868. In Vitro Activity of Isavuconazole and Other Mould-Active Triazoles Against Aspergillus fumigatus With and Without cyp51 Alterations

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

347. Azole Activity against Filamentous Fungi Causing Invasive Infections in Patients from ICU and Non-ICU Units (2017-2021)

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against IAspergillus fumigatus/I with and without CYP51 Alterations

Journal of fungi (Basel), 2023-05, Vol.9 (6)

2023

Volltextzugriff (PDF)

1240. Ceftobiprole Activity against Drug-Resistant Staphylococcus aureus Clinical Isolates Collected in the United States from 2016 through 2020

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S709-S710

2021

Volltextzugriff (PDF)

1076. Activity of Rezafungin and Comparator Antifungal Agents Tested Against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019-2020)

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S628-S628

2021

Volltextzugriff (PDF)

1253. In Vitro Activity of Omadacycline against 7000 Bacterial Pathogens from the United States Stratified by Infection Type (2019)

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S644-S644

2020

Volltextzugriff (PDF)

1595. Ceftobiprole Activity against Gram-Positive Pathogens Causing Bone and Joint Infections in the United States from 2016 through 2019

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S794-S794

2020

Volltextzugriff (PDF)

Manual of Clinical Microbiology, 8th Edition:Manual of Clinical Microbiology, 8th Edition

Clinical infectious diseases, 2004-04, Vol.38 (8), p.1199-1200

2004

Volltextzugriff (PDF)

1260. Activity of Manogepix (APX001A) against 2,669 Fungal Isolates from the SENTRY Surveillance Program (2018-2019) Stratified by Infection Type

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S646-S647

2020

Volltextzugriff (PDF)

665. In vitro Activity of Omadacycline Against Recent (2018) Bacterial Pathogens from the United States and Europe Obtained from Skin and Skin Structure, Respiratory, and Urinary Tract Infections

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S305-S305

2019

Volltextzugriff (PDF)

2115. Activity of a Long-Acting Echinocandin Rezafungin and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates: SENTRY 2018

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S716-S716

2019

Volltextzugriff (PDF)

1258. Activity of a Series of Investigational Compounds Tested Against Invasive Fungal Isolates

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S645-S646

2020

Volltextzugriff (PDF)

1004. Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria Isolated From Patients Hospitalized With Bloodstream Infections in United States Medical Centers (2015–2017)

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S299-S299

2018

Volltextzugriff (PDF)

1 – 25 von 403

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

ThemaMycology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(325)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(50)
Medical Sciences
(36)
Infectious Disease
(34)
Humans
(33)
Antimicrobial Susceptibilities
(27)
Serologic Tests
(27)
Bacteriology
(21)
Pharmacology. Drug Treatments
(21)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(20)
Fundamental And Applied Biological Sciences. Psychology
(19)
Science & Technology
(19)
Microbiology
(18)
Abstracts
(17)
Infectious Diseases
(17)
Typing Systems
(15)
Antigen Detection
(14)
Antibacterial Agents
(13)
Microbial Sensitivity Tests
(13)
Cross Infection - Epidemiology
(11)
Nucleic Acid Detection
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

Clade-Specific Flucytosine Resistance Is Due to a Single Nucleotide Change in the FUR1 Gene of Candida albicans

Correction: Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019)

Invasive Mycoses: Evolving Challenges and Opportunities in Antifungal Therapy (Multimedia Activity)

Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012–2014

Manual of Clinical Microbiology

Evaluation of the in vitro activity of daptomycin against 19 615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002–2005)

Molecular Medical Microbiology, Three-Volume Set

Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy

Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial

Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program

1292. Activity of Omadacycline and Comparators Against 876 Bacterial Clinical Isolates from Patients with Bone and Joint Infections in the United States and Europe (2015–2022)

868. In Vitro Activity of Isavuconazole and Other Mould-Active Triazoles Against Aspergillus fumigatus With and Without cyp51 Alterations

347. Azole Activity against Filamentous Fungi Causing Invasive Infections in Patients from ICU and Non-ICU Units (2017-2021)

In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against IAspergillus fumigatus/I with and without CYP51 Alterations

1240. Ceftobiprole Activity against Drug-Resistant Staphylococcus aureus Clinical Isolates Collected in the United States from 2016 through 2020

1076. Activity of Rezafungin and Comparator Antifungal Agents Tested Against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019-2020)

1253. In Vitro Activity of Omadacycline against 7000 Bacterial Pathogens from the United States Stratified by Infection Type (2019)

1595. Ceftobiprole Activity against Gram-Positive Pathogens Causing Bone and Joint Infections in the United States from 2016 through 2019

Manual of Clinical Microbiology, 8th Edition:Manual of Clinical Microbiology, 8th Edition

1260. Activity of Manogepix (APX001A) against 2,669 Fungal Isolates from the SENTRY Surveillance Program (2018-2019) Stratified by Infection Type

665. In vitro Activity of Omadacycline Against Recent (2018) Bacterial Pathogens from the United States and Europe Obtained from Skin and Skin Structure, Respiratory, and Urinary Tract Infections

2115. Activity of a Long-Acting Echinocandin Rezafungin and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates: SENTRY 2018

1258. Activity of a Series of Investigational Compounds Tested Against Invasive Fungal Isolates

1004. Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria Isolated From Patients Hospitalized With Bloodstream Infections in United States Medical Centers (2015–2017)

Aktive Filter

Suchergebnisse filtern